
Puya Agahi
Examiner (ID: 8645, Phone: (571)270-1906 , Office: P/3735 )
| Most Active Art Unit | 3791 |
| Art Unit(s) | 3735, 3791 |
| Total Applications | 620 |
| Issued Applications | 259 |
| Pending Applications | 107 |
| Abandoned Applications | 280 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8483245
[patent_doc_number] => 20120282652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'PREPARATION OF PEPTIDE MIXTURES BY PROTEASE CATALYSIS DESIGNED TO PROVIDE USEFUL BIOLOGICAL AND PHYSICAL PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 13/406751
[patent_app_country] => US
[patent_app_date] => 2012-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20402
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13406751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/406751 | PREPARATION OF PEPTIDE MIXTURES BY PROTEASE CATALYSIS DESIGNED TO PROVIDE USEFUL BIOLOGICAL AND PHYSICAL PROPERTIES | Feb 27, 2012 | Abandoned |
Array
(
[id] => 9181213
[patent_doc_number] => 20130323199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-05
[patent_title] => 'COLLAGEN MATERIAL AND METHOD FOR PRODUCING COLLAGEN MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 14/000397
[patent_app_country] => US
[patent_app_date] => 2012-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8495
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000397
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/000397 | Collagen material and method for producing collagen material | Feb 19, 2012 | Issued |
Array
(
[id] => 8228399
[patent_doc_number] => 20120142594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'Von Willebrand Factor- and Factor VIII-Polymer Conjugates Having a Releasable Linkage'
[patent_app_type] => utility
[patent_app_number] => 13/371275
[patent_app_country] => US
[patent_app_date] => 2012-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 35981
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13371275
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/371275 | Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage | Feb 9, 2012 | Issued |
Array
(
[id] => 13968261
[patent_doc_number] => 10213464
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Method for enhancing engraftment of haematopoetic stem cells
[patent_app_type] => utility
[patent_app_number] => 13/979332
[patent_app_country] => US
[patent_app_date] => 2012-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8041
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979332
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979332 | Method for enhancing engraftment of haematopoetic stem cells | Jan 12, 2012 | Issued |
Array
(
[id] => 8313078
[patent_doc_number] => 20120190096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 13/329002
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 29222
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13329002
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/329002 | Materials and methods for conjugating a water soluble fatty acid derivative to a protein | Dec 15, 2011 | Issued |
Array
(
[id] => 8625284
[patent_doc_number] => 08357779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-22
[patent_title] => 'Polymer-von Willebrand factor-conjugates'
[patent_app_type] => utility
[patent_app_number] => 13/305334
[patent_app_country] => US
[patent_app_date] => 2011-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16586
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13305334
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/305334 | Polymer-von Willebrand factor-conjugates | Nov 27, 2011 | Issued |
Array
(
[id] => 9107623
[patent_doc_number] => 20130280755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'THERAPEUTIC METHODS FOR SOLID DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/988309
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21617
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988309
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/988309 | THERAPEUTIC METHODS FOR SOLID DELIVERY | Nov 22, 2011 | Abandoned |
Array
(
[id] => 8335103
[patent_doc_number] => 20120201804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'TISSUE KALLIKREIN FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER'
[patent_app_type] => utility
[patent_app_number] => 13/278933
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8683
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13278933
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/278933 | TISSUE KALLIKREIN FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER | Oct 20, 2011 | Abandoned |
Array
(
[id] => 8277315
[patent_doc_number] => 20120171188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'Artificial Peptidoglycan Lysing Enzymes and Peptidoglycan Binding Proteins'
[patent_app_type] => utility
[patent_app_number] => 13/251896
[patent_app_country] => US
[patent_app_date] => 2011-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12764
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13251896
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/251896 | Artificial Peptidoglycan Lysing Enzymes and Peptidoglycan Binding Proteins | Oct 2, 2011 | Abandoned |
Array
(
[id] => 8394410
[patent_doc_number] => 20120232252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'FACTOR VIII POLYMER CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 13/243550
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8617
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13243550
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/243550 | FACTOR VIII POLYMER CONJUGATES | Sep 22, 2011 | Abandoned |
Array
(
[id] => 10040322
[patent_doc_number] => 09081024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Method for in vitro assay of soluble fibrin by generating specific degradation products'
[patent_app_type] => utility
[patent_app_number] => 13/242996
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4273
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13242996
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/242996 | Method for in vitro assay of soluble fibrin by generating specific degradation products | Sep 22, 2011 | Issued |
Array
(
[id] => 8054023
[patent_doc_number] => 20120076749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Modified Blood Factors Comprising a Low Degree of Water Soluble Polymer'
[patent_app_type] => utility
[patent_app_number] => 13/242934
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15918
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20120076749.pdf
[firstpage_image] =>[orig_patent_app_number] => 13242934
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/242934 | Modified Blood Factors Comprising a Low Degree of Water Soluble Polymer | Sep 22, 2011 | Abandoned |
Array
(
[id] => 8054937
[patent_doc_number] => 20120077204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Detection of Protein Translocation by Beta-Galactosidase Reporter Fragment Complementation'
[patent_app_type] => utility
[patent_app_number] => 13/237841
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18810
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077204.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237841
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237841 | Detection of protein translocation by beta-galactosidase reporter fragment complementation | Sep 19, 2011 | Issued |
Array
(
[id] => 8208987
[patent_doc_number] => 20120128652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'ENDOLYSIN PLYP40'
[patent_app_type] => utility
[patent_app_number] => 13/230642
[patent_app_country] => US
[patent_app_date] => 2011-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6393
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20120128652.pdf
[firstpage_image] =>[orig_patent_app_number] => 13230642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/230642 | ENDOLYSIN PLYP40 | Sep 11, 2011 | Abandoned |
Array
(
[id] => 10856951
[patent_doc_number] => 08883144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Treatment of pulmonary vascular remodeling with neprilysin'
[patent_app_type] => utility
[patent_app_number] => 13/224126
[patent_app_country] => US
[patent_app_date] => 2011-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 42381
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13224126
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/224126 | Treatment of pulmonary vascular remodeling with neprilysin | Aug 31, 2011 | Issued |
Array
(
[id] => 7766923
[patent_doc_number] => 20120034614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'EARLY DETECTION OF PATHOGENS IN BLOOD'
[patent_app_type] => utility
[patent_app_number] => 13/207894
[patent_app_country] => US
[patent_app_date] => 2011-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 4721
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034614.pdf
[firstpage_image] =>[orig_patent_app_number] => 13207894
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/207894 | EARLY DETECTION OF PATHOGENS IN BLOOD | Aug 10, 2011 | Abandoned |
Array
(
[id] => 7768368
[patent_doc_number] => 20120035344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE'
[patent_app_type] => utility
[patent_app_number] => 13/194038
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 85380
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035344.pdf
[firstpage_image] =>[orig_patent_app_number] => 13194038
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/194038 | Nucleophilic catalysts for oxime linkage | Jul 28, 2011 | Issued |
Array
(
[id] => 7727524
[patent_doc_number] => 20120012487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'Biological Tissue for Surgical Implantation'
[patent_app_type] => utility
[patent_app_number] => 13/189036
[patent_app_country] => US
[patent_app_date] => 2011-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3985
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20120012487.pdf
[firstpage_image] =>[orig_patent_app_number] => 13189036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/189036 | Biological tissue for surgical implantation | Jul 21, 2011 | Issued |
Array
(
[id] => 7710163
[patent_doc_number] => 20120003202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'CNS DELIVERY OF THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/168961
[patent_app_country] => US
[patent_app_date] => 2011-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 163
[patent_figures_cnt] => 163
[patent_no_of_words] => 93707
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168961
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168961 | CNS delivery of therapeutic agents | Jun 24, 2011 | Issued |
Array
(
[id] => 10600163
[patent_doc_number] => 09320711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-26
[patent_title] => 'Methods and compositions for CNS delivery of heparan N-sulfatase'
[patent_app_type] => utility
[patent_app_number] => 13/168957
[patent_app_country] => US
[patent_app_date] => 2011-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 64
[patent_no_of_words] => 44697
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168957
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168957 | Methods and compositions for CNS delivery of heparan N-sulfatase | Jun 24, 2011 | Issued |